
Sign up to save your podcasts
Or


Lisa Salberg and Dr. Ahmed Masri break down the SONATA HCM clinical trial and a new approach that targets metabolism, not just pressure, in the heart. They explain who may qualify, what to expect, and why patient participation is critical to advancing better treatments for both obstructive and non-obstructive HCM.
This conversation was recorded April 14, 2026
By Hypertrophic Cardiomyopathy Association / Lisa Salberg5
88 ratings
Lisa Salberg and Dr. Ahmed Masri break down the SONATA HCM clinical trial and a new approach that targets metabolism, not just pressure, in the heart. They explain who may qualify, what to expect, and why patient participation is critical to advancing better treatments for both obstructive and non-obstructive HCM.
This conversation was recorded April 14, 2026

78,688 Listeners

37,595 Listeners

12,103 Listeners

113,121 Listeners

56,944 Listeners

16,512 Listeners

47,718 Listeners